Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
07 May, 2026, 08.10 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
22 Apr, 2026, 10.08 PM IST
This surprising diet helps Type 1 Diabetes patients slash their insulin useA new study suggests a low-fat vegan diet can significantly reduce insulin needs for type 1 diabetes patients. This dietary change may also...
23 Oct, 2025, 01.12 AM IST
Game changer: California launches $11 state brand to slash Diabetes costsCalifornia is set to launch its own low cost insulin under the CalRx beginning from January 1, 2026, representing a major step in the state...
17 Oct, 2025, 11.29 PM IST
Twitter prank spurs unexpected scrutiny of insulin pricesAmong the victims was drugmaker Eli Lilly, whose stock price nosedived -- erasing billions in market capitalization -- after a parody accou...
15 Nov, 2022, 07.40 AM IST
Most of House Republicans in US vote against capping price of insulinThe US House of Representatives has passed a bill popularly known as the Insulin Price Bill that limits insulin costs to $35 per month. The...
01 Apr, 2022, 08.28 PM IST
Biocon to reduce insulin prices to 10 cents per dayKiran Mazumdar Shaw, chairperson and managing director, Biocon said accessibility of insulin has been a major concern over the years due to...
26 Sep, 2019, 05.49 PM IST
- NPPA’s price ceiling on insulin absurd, will encourage imports: Kiran Mazumdar-Shaw, Biocon
In an interview with ET Now, Kiran Mazumdar-Shaw, CMD, Biocon, talks about NPPA’s price ceiling on insulin and its effects on Biocon.
21 Nov, 2012, 12.01 PM IST
- Biocon, Wockhardt slip on NPPA insulin ceiling order
Shares of Biocon and Wockhardt were witnessing selling pressure after NPPA imposed a blanket ceiling on insulin prices, irrespective of the...
21 Nov, 2012, 10.53 AM IST
- Wockhardt to raise insulin prices; stock down
The drug price regulator has allowed local pharma companies Wockhardt and Biocon to increase prices of their insulin brands due to rising i...
17 Mar, 2011, 02.27 PM IST
- Wockhardt, Biocon allowed to raise Insulin prices by 18%
NPPA has slashed the price of anti-asthma bulk drug used in popular brands such as Cipla's Asthalin, by 18% to Rs 3,633 per kg.
17 Mar, 2011, 05.06 AM IST
- Biocon is at a strong price disadvantage to global players : Kiran Mazumdar Shaw
The National Pharmaceutical Pricing Authority has allowed pharma cos to increase the price of insulin drugs. Kiran Mazumdar Shaw, Chairpers...
29 Dec, 2010, 03.29 PM IST
- Insulin prices may come down by 70 per cent
Insulin prices are likely to fall by up to 70 per cent as drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has bro...
06 Aug, 2009, 09.26 PM IST
- Wockhardt, Biocon insulin prices to fall by 70%
Indian copycats of French drug maker Sanofi Aventis’ premium insulin formulation, Lantus, will soon become about 70% cheaper with the count...
04 Aug, 2009, 02.59 AM IST
- Insulin prices to pinch less as regulator plans ceiling
More than three crore diabetics in the country can look forward to a sharp fall in human insulin prices.
01 May, 2008, 04.35 AM IST